A Jefferson Health interventional radiologist became the first physician in the Philadelphia/South Jersey region to perform a new procedure that creates an arteriovenous (AV) fistula, necessary for ...
Humacyte (($HUMA)) announced an update on their ongoing clinical study. Humacyte (HUMA) has initiated a Phase 3 clinical trial titled A Phase 3 ...
Overlook Medical Center, part of Atlantic Health System, has unveiled the WavelinQ, a device that offers a new, non-surgical way to prepare patients for dialysis. According to Overlook officials, it ...
In a related press release, lead author Gerald A. Beathard, MD, PhD, of the University of Texas Medical Branch, said, “The dramatic difference in durability between the endovascular fistulas and the ...
Concept Medical has been granted "IDE Approval" from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for ...
This protocol describes the different steps to establish a murine model of restenosis after angioplasty of a stenotic arteriovenous fistula (AVF), including a detailed description of the partial ...
WASHINGTON--(BUSINESS WIRE)--The FDA-approved Ellipsys® Vascular Access System from Avenu Medical, Inc., became a key focus of attention throughout last week’s Controversies in Dialysis Access (CiDA) ...
SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical Inc., a company dedicated to developing and commercializing its breakthrough AlucentNVS technology for the treatment of vascular disease, announced ...
Please provide your email address to receive an email when new articles are posted on . Austin, Texas-based TVA Medical Inc. released positive results from a clinical study evaluating the everlinQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback